NCT06836687 (EFS-ILAE2014) is a clinical trial in Seizure, Epileptic, sponsored by University Hospital Marburg.

Who is sponsoring NCT06836687?

NCT06836687 is sponsored by University Hospital Marburg.

What condition does NCT06836687 study?

NCT06836687 studies Seizure, Epileptic, Neuropsychology, Outcome.

Is NCT06836687 still recruiting?

NCT06836687 is currently recruiting now. Last updated 20 February 2025.

Last reviewed 2025-02-20 · How we verify

NCT06836687: EFS-ILAE2014

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure

Recruiting now Last updated 20 February 2025

What this trial tests

trial in Seizure, Epileptic in 1,000 participants. Currently enrolling.

Timeline

1 March 2018

Primary endpoint
1 April 2038

1 August 2038

Quick facts

Lead sponsor	University Hospital Marburg
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 March 2018
Primary completion	1 April 2038
Estimated completion	1 August 2038
Sites	1 location across Germany

Conditions studied

Seizure, Epileptic — all drugs for Seizure, Epileptic →
Neuropsychology — all drugs for Neuropsychology →
Outcome — all drugs for Outcome →

Sponsor

University Hospital Marburg

Who can join

18 and older, any sex, with Seizure, Epileptic or Neuropsychology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study is a prospective study on the development of seizure frequency, medication adherence, quality of life and cognitive performance after a first epileptic seizure using the new diagnostic criteria for epilepsy of the International League Against Epilepsy of 2014 at the time of diagnosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The impact of white matter lesions on seizure recurrence after first epileptic seizures in the elderly: a prospective study.
Weil J, Linka L, Gurschi M, Kidik SA, et al · · 2025 · PMID 40394715 · DOI 10.1186/s42466-025-00391-2

Verify or expand the search:

Other recruiting trials for Seizure, Epileptic

Currently open trials in the same condition.

NCT05459597 — Antiepileptic Drugs in Elderly Patients · recruiting

Other University Hospital Marburg trials

Trials by the same sponsor.

NCT06765018 — Tongue Brush (Orabrush) for Reducing Aspiration Pneumonia in Stroke Patients · NA · completed
NCT06013761 — IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant E · NA · completed
NCT07443241 — Status Epilepticus in Men and Women: Clinical Presentation, Management, and Outcomes · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06836687 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Marburg
Last refreshed: 20 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06836687.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing